Abstract
Bariatric surgery has evolved over the years from nonreversible procedures that focused on malabsorption to the more patient-friendly restrictive procedures, as well as hybrid procedures. There is sufficient evidence in literature to indicate that obesity is a risk factor for abdominal malignancies. While it is postulated that these risks may reduce after successful bariatric surgery, the risk that the process of carcinogenesis may have already commenced leading to the malignancy presenting at variable periods after the surgery is real. This chapter provides the most updated evidence for the diagnosis and surgical management of abdominal malignancies presenting following bariatric surgery while acknowledging areas of paucity of data and the need for awareness amongst clinicians when interpreting symptoms in this unique subset of patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i–xii, 1–253.
Steffen A, Huerta JM, Weiderpass E, Bueno-de-Mesquita HB, May AM, Siersema PD, et al. General and abdominal obesity and risk of esophageal and gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2015;137(3):646–57.
Lin XJ, Wang CP, Liu XD, Yan KK, Li S, Bao HH, et al. Body mass index and risk of gastric cancer. A meta-analysis. Jpn J Clin Oncol. 2014;44(9):783–91.
Aune D, Greenwood DC, Chan DS, Vieira R, Vieira AR, Navarro Rosenblatt DA, et al. Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies. Ann Oncol. 2012;23(4):843–52.
Jiao L, Berrington de Gonzalez A, Hartge P, Pfeiffer RM, Park Y, Freedman DM, et al. Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts. Cancer Causes Control. 2010;21(8):1305–14.
Ma Y, Yang Y, Wang F, Zhang P, Shi C, Zou Y, et al. Obesity and risk of colorectal cancer: a systematic review of prospective studies. PLoS One. 2013;8(1):e53916.
Larsson SC, Wolk A. Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. Br J Cancer. 2007;97(7):1005–8.
Cheraghi Z, Poorolajal J, Hashem T, Esmailnasab N, Doosti IA. Effect of body mass index on breast cancer during premenopausal and postmenopausal periods: a meta-analysis. PLoS One. 2012;7(12):e51446.
Zhang Y, Liu H, Yang S, Zhang J, Qian L, Chen X. Overweight, obesity and endometrial cancer risk: results from a systematic review and meta-analysis. Int J Biol Markers. 2014;29(1):e21–9.
Poorolajal J, Jenabi E, Masoumi SZ. Body mass index effects on risk of ovarian cancer: a meta- analysis. Asian Pac J Cancer Prev. 2014;15(18):7665–71.
Turati F, Tramacere I, La Vecchia C, Negri E. A meta-analysis of body mass index and esophageal and gastric cardia adenocarcinoma. Ann Oncol. 2013;24(3):609–17.
Taghizadeh N, Boezen HM, Schouten JP, Schroder CP, Vries EG, Vonk JM. BMI and lifetime changes in BMI and cancer mortality risk. PLoS One. 2015;10(4):e0125261.
Mathur A, Luberice K, Paul H, Franka C, Rosemurgy A. Increasing body mass index portends abbreviated survival following pancreatoduodenectomy for pancreatic adenocarcinoma. Am J Surg. 2015;209(6):969–73.
Health Quality Ontario. Bariatric surgery: an evidence-based analysis. Ont Health Technol Assess Ser. 2005;5(1):1–148.
Maestro A, Rigla M, Caixas A. Does bariatric surgery reduce cancer risk? A review of the literature. Endocrinol Nutr. 2015;62(3):138–43.
McCawley GM, Ferriss JS, Geffel D, Northup CJ, Modesitt SC. Cancer in obese women: potential protective impact of bariatric surgery. J Am Coll Surg. 2009;208(6):1093–8.
Lazzati A, Guy-Lachuer R, Delaunay V, Szwarcensztein K, Azoulay D. Bariatric surgery trends in France: 2005–2011. Surg Obes Relat Dis. 2014;10(2):328–34.
Sundbom M. Laparoscopic revolution in bariatric surgery. World J Gastroenterol. 2014;20(41):15135–43.
Ostlund MP, Lu Y, Lagergren J. Risk of obesity-related cancer after obesity surgery in a population-based cohort study. Ann Surg. 2010;252(6):972–6.
Franco J, Ruiz P, Palermo M, Gagner M. A review of studies comparing three laparoscopic procedures in bariatric surgery: sleeve gastrectomy, Roux-en-Y gastric bypass and adjustable gastric banding. Obes Surg. 2011;21(9):1458–68.
DePergola G, Silvestris F. Obesity as a major risk factor for cancer. J Obes. 2013;2013:291546.
Mantovani P, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436–44.
Balaban S, Lee L, Schreuder M, Hoy A. Obesity and cancer progression: is there a role of fatty acid metabolism. Biomed Res Int. 2015;2015:274585.
Byun JS, Gardner K. C-terminal binding protein: A molecular link between metabolic imbalance and epigenetic regulation in breast cancer. Int J Cell Biol. 2013;2013:647975.
Di LJ, Byun JS, Wong MM, Wakano C, Taylor T, Bilke S, et al. Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancer. Nat Commun. 2013;4:1449.
Webb PM. Obesity and gynecologic cancer etiology and survival. Am Soc Clin Oncol Educ Book. 2013 doi:10.1200/EdBook_AM.2013.33.e222.
Kuruba R, Jawad M, Karl R, Murr M. Technique of resection of esophageal adenocarcinoma after Roux-e-Y gastric bypass and literature review of esophagogastric tumors after bariatric procedures. Surg Obes Relat Dis. 2009;5:576–81.
Arndt V, Sturmer T, Stegmaier C, Ziegler H, Dhom G, Brenner H. Patient delay and stage of diagnosis among breast cancer patients in Germany—a population based study. Br J Cancer. 2002;86(7):1034–40.
Kim Y, Lee C. Effects of obesity on breast cancer stage at diagnosis in Korean women. Eur J Cancer Prev. 2004;13(1):13–7.
Wee C, McCarthy E, Davis R, Phillips R. Screening for cervical and breast cancer: is obesity an unrecognised barrier to preventive care? Ann Intern Med. 2000;132(9):697–704.
Henretta MS, Copeland AR, Kelley SL, Hallowell PT, Modesitt SC. Perceptions of obesity and cancer risk in female bariatric surgery candidates: highlighting the need for physician action for unsuspectingly obese and high risk patients. Gynecol Oncol. 2014;133(1):73–7.
Scozzari G, Trapani R, Toppino M, Morino M. Esophagogastric cancer after bariatric surgery: systematic review of the literature. Surg Obes Relat Dis. 2013;9(1):133–42.
Swain J, Adams R, Farnell M, Que F, Sarr M. Gastric and pancreatoduodenal resection for malignant lesions after previous gastric bypass—diagnosis and methods of reconstruction. Surg Obes Relat Dis. 2010;6(6):670–5.
Melstrom LG, Bentrem DJ, Salvino MJ, Blum MG, Talamonti MS, Printen KJ. Adenocarcinoma of the gastroesophageal junction after bariatric surgery. Am J Surg. 2008;196(1):135–8.
Bauchowitz AU, Gonder-Frederick LA, Olbrisch ME, Azarbad L, Ryee MY, Woodson M, et al. Psychosocial evaluation of bariatric surgery candidates: a survey of present practices. Psychosom Med. 2005;67(5):825–32.
American College of Surgeons. Recommendations for facilities performing bariatric surgery. Bull Am Coll Surg. 2000;85(9):20–3.
Guidelines for Clinical Application of Laparoscopic Bariatric Surgery. SAGES Guidelines Committee endorsed by the ASMBS. http://www.sagescms.org.
Levine M, Carucci L. Imaging of bariatric surgery: normal anatomy and postoperative complications. Radiology. 2014;270(2):327–41.
Watkins B, Blackmun S, Kuehner M. Gastric adenocarcinoma after Roux-en-Y gastric bypass: access and evaluation of the excluded stomach. Surg Obes Relat Dis. 2007;3(6):644–7.
Sinar DR, Flickinger EG, Park HK, Sloss RR. Retrograde endoscopy of the bypassed stomach segment after gastric bypass surgery: unexpected lesions. South Med J. 1985;78(3):255–8.
Sakai P, Kuga R, Safatle-Ribeiro A, Faintuch J. Is it feasible to reach the bypassed stomach after Roux-en-Y gastric bypass for morbid obesity? The use of the double balloon enteroscope. Endoscopy. 2005;37(6):566–9.
Tagaya N, Kasama K, Inamine S, Zaha O. Evaluation of the excluded stomach by double-balloon endoscopy after laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2007;17(9):1165–70.
Kuga R, Safatle-Ribeiro A, Faintuch J, et al. Endoscopic findings in the excluded stomach after Roux-en-Y gastric bypass surgery. Arch Surg. 2007;142:942–6.
Gill KR, McKinney JM, Stark ME, Bouras EP. Investigation of the excluded stomach after Roux-en-Y gastric bypass: the role of percutaneous endoscopy. World J Gastroenterol. 2008;14(12):1946–8.
Ceppa FA, Gagne DJ, Papasavas PK, Caushaj PF. Laparoscopic transgastric endoscopy after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2007;3(1):21–4.
Fobi MA, Chicola K, Lee H. Access to the bypassed stomach after gastric bypass. Obes Surg. 1998;8(3):289–95.
Sundbom M, Nyman R, Hedenstrom H, Gustavsson S. Investigation of the excluded stomach after Roux-en-Y gastric bypass. Obes Surg. 2001;11(1):25–7.
Goitein D, Gagne D, Papasavas P, McLean G, Foster R, Beasley H, et al. Percutaneous computed tomography-guided gastric remnant access after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2006;2006(2):6.
Silecchia G, Catalano C, Gentileschi P, Elmore U, Restuccia A, Gagner M, et al. Virtual gastroduodenoscopy: a new look at the bypassed stomach and duodenum after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Obes Surg. 2002;12(1):39–48.
Alva S, Eisenberg D, Duffy A, Roberts K, Israel G, Bell R. A new modality to evaluate the gastric remnant after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2008;4(1):46–9; discussion 9.
Shrikhande S, Barreto S, Goel M, Arya S. Multimodality imaging of pancreatic ductal adenocarcinoma: A review of the literature. HPB (Oxford). 2012;14(10):658–68.
Asbun HJ, Conlon K, Fernandez-Cruz L, Friess H, Shrikhande SV, Adham M, et al. When to perform a pancreatoduodenectomy in the absence of positive histology? A consensus statement by the International Study Group of Pancreatic Surgery. Surgery. 2014;155(5):887–92.
Park CM, Park JS, Cho ES, Kim JK, Yu JS, Yoon DS. The effect of visceral fat mass on pancreatic fistula after pancreaticoduodenectomy. J Invest Surg. 2012;25(3):169–73.
Shimizu A, Tani M, Kawai M, Hirono S, Miyazawa M, Uchiyama K, et al. Influence of visceral obesity for postoperative pulmonary complications after pancreaticoduodenectomy. J Gastrointest Surg. 2011;15(8):1401–10.
Park B, Park J, Ryoo S, Jeong S, Park K, Park J. Effect of visceral obesity on surgical outcomes of patients undergoing laparoscopic colorectal surgery. World J Surg. 2015;39(9):2343–53.
Watanabe J, Tatsumi K, Ota M, Suwa Y, Suzuki S, Watanabe A, et al. The impact of visceral obesity on surgical outcomes of laparosocpic surgery for colon cancer. Int J Colorectal Dis. 2014;29(3):343–51.
Fortin C, Saed G, Diamond M. Predisposing factors to post-operative adhesion development. Hum Reprod Update. 2015;21(4):536–51.
Hatzaras I, Sachs TE, Weiss M, Wolfgang CL, Pawlik TM. Pancreaticoduodenectomy after bariatric surgery: challenges and available techniques for reconstruction. J Gastrointest Surg. 2014;18(4):869–77.
Acknowledgements
Dr. Ravi Chaudhary, Consultant Radiologist, Medanta—The Medicity for providing the radiological images; Mr. Biraj Dutta, Medical Illustrator, and Dr. Ankesh Rawat, Medical Officer Medanta—The Medicity, for work on the illustrations in the manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Malhotra, S., Barreto, S.G. (2017). Surgery for Cancer After Previous Bariatric Surgery. In: Fong, Y., Kauffmann, R., Marcinkowski, E., Singh, G., Schoellhammer, H. (eds) Surgical Emergencies in the Cancer Patient. Springer, Cham. https://doi.org/10.1007/978-3-319-44025-5_27
Download citation
DOI: https://doi.org/10.1007/978-3-319-44025-5_27
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-44023-1
Online ISBN: 978-3-319-44025-5
eBook Packages: MedicineMedicine (R0)